Time (days) | −7 | 1 | 8 | 15 | 22 | 29 | 36 | 43 | 64 | 92 |
---|---|---|---|---|---|---|---|---|---|---|
LAI PBO | 0.6 (1.64) | 0.7 (1.8) | 0.7 (1.96) | 1.2 (2.81) | – | – | 0.9 (1.91) | 0.9 (1.53) | 1.1 (2.7) | 0.6 (1.53) |
LAI 25 mg | 0.7 (1.87) | 0.6 (1.78) | 0.6 (1.6) | – | – | – | – | – | – | 0.6 (1.8) |
LAI 50 mg | 0.9 (2.13) | 0.9 (1.93) | 0.8 (1.88) | 0.9 (1.76) | – | – | 0.6 (1.42) | 0.6 (1.47) | 0.5 (1.41) | 0.8 (1.86) |
LAI 100 mg | 0.8 (1.93) | 0.7 (1.75) | 0.6 (1.74) | 0.7 (1.55) | – | – | 0.7 (2.17) | 0.5 (1.14) | 0.5 (1.28) | 0.5 (1.47) |
LAI 150 mg | 0.8 (2.37) | 0.8 (2.29) | 0.8 (2.17) | – | – | – | – | – | – | 0.8 (2.38) |
Oral PBO | – | 0.8 (1.91) | 0.8 (1.98) | 0.7 (1.79) | 0.6 (1.59) | 0.7 (1.81) | 0.7 (1.79) | 0.7 (1.63) | – | – |
Oral 3 mg | – | 0.6 (1.59) | 0.7 (1.86) | 0.8 (2.04) | 0.7 (1.88) | 0.6 (1.65) | 0.4 (1.14) | 0.5 (1.4) | – | – |
Oral 6 mg | – | 0.6 (1.71) | 0.6 (1.53) | 0.5 (1.49) | 0.5 (1.38) | 0.6 (1.44) | 0.6 (1.55) | 0.5 (1.42) | – | – |
Oral 9 mg | – | 0.4 (1.27) | 0.5 (1.51) | 0.4 (1.14) | 0.5 (1.32) | 0.5 (1.1) | 0.4 (1.07) | 0.4 (1.03) | – | – |
Oral 12 mg | – | 0.5 (1.55) | 0.5 (1.43) | 0.5 (1.47) | 0.5 (1.38) | 0.5 (1.54) | 0.5 (1.75) | 0.3 (1.4) | – | – |
Oral 15 mg | – | 0.7 (1.86) | 0.5 (1.56) | 0.5 (1.73) | 0.6 (1.67) | 0.6 (1.57) | 0.6 (1.7) | 0.5 (1.83) | – | – |
Oral OLZ | – | 0.6 (1.79) | 0.6 (1.58) | 0.5 (1.39) | 0.4 (1.33) | 0.3 (1.08) | 0.4 (1.35) | 0.3 (1.26) | – | – |
Abbreviations: LAI, long-acting injectable; OLZ, olanzapine; PBO, placebo.